Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

IMUC EOM Pharmaceutical Holdings

Watchlist
0.6200.0000.00%
Close  02/01 16:00 ET
High
0.620
Open
0.620
Turnover
70.68
Low
0.620
Pre Close
0.620
Volume
114.00
Market Cap
2.60M
P/E(TTM)
0.04
52wk High
0.940
Shares
4.19M
P/E(Static)
Loss
52wk Low
0.150
Float Cap
2.59M
Bid/Ask %
0.00%
Historical High
1600.000
Shs Float
4.18M
Volume Ratio
0.11
Historical Low
0.059
Dividend TTM
--
Div Yield TTM
--
P/B
0.76
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.620
Lot Size
1
Float Cap
2.59M
Bid/Ask %
0.00%
Historical High
1600.000
Shs Float
4.18M
Volume Ratio
0.11
Historical Low
0.059
Dividend TTM
--
P/B
0.76
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
0.620
Lot Size
1
Price Forecast

News

Comment

Company Overview More
ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.
CEO: --
Market: Pink Market
Listing Date: 08/11/2016
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist